Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Physiologically Based Pharmacokinetic Modeling of Vedolizumab in Healthy Adults and Patients with Inflammatory Bowel Disease.
Journal: Clinical pharmacokinetics
Published: March 11, 2026
The Safety and Effectiveness of Early Anti-Tumor-Necrosis-Factor Therapy for Penetrating Crohn's Disease Complications in Children.
Journal: The American journal of gastroenterology
Published: February 23, 2026
Pharmacometric Targets During Anti-TNF Induction and Their Association with Deep Remission in Pediatric Crohn's Disease.
Journal: Clinical pharmacokinetics
Published: January 14, 2026
CAPTURE IBD: Advancing Precision Medicine in Pediatric IBD.
Journal: Inflammatory bowel diseases
Published: September 22, 2025
Markers of Gut Inflammation in Pediatric Acute Pancreatitis.
Journal: Pancreas
Published: September 11, 2025
Model-informed Deep Q-Networks to Guide Infliximab Dosing in Pediatric Crohn's Disease.
Journal: bioRxiv : the preprint server for biology
Published: August 12, 2025
Evaluation of pharmacokinetic metrics and pharmacodynamic biomarkers associated with endoscopic healing in pediatric Crohn's disease patients treated with anti-tumor necrosis factor biologics.
Journal: Crohn's & colitis 360
Published: August 05, 2025
Hybrid Population PK-Machine Learning Modeling to Predict Infliximab Pharmacokinetics in Pediatric and Young Adult Patients with Crohn's Disease.
Journal: bioRxiv : the preprint server for biology
Published: July 14, 2025
Model-Informed Deep Q-Networks to Guide Infliximab Dosing in Pediatric Crohn's Disease.
Journal: Clinical pharmacology and therapeutics
Published: July 14, 2025
Hybrid Population Pharmacokinetic-Machine Learning Modeling to Predict Infliximab Pharmacokinetics in Pediatric and Young Adult Patients with Crohn's Disease.
Journal: Clinical pharmacokinetics
Published: May 01, 2025
Comment on a Risk Stratification Tool for Relapse After Intravenous-to-Subcutaneous Switching of Infliximab in Patients With Inflammatory Bowel Diseases.
Journal: The American journal of gastroenterology
Published: April 24, 2025
Machine Learning Modeling for Predicting Infliximab Pharmacokinetics in Pediatric and Young Adult Patients With Crohn Disease: Leveraging Ensemble Modeling With Synthetic and Real-World Data.
Journal: Therapeutic drug monitoring
Published: March 03, 2025
Last Updated: 09/26/2026